Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FeNO for predicting ICS response in non-specific respiratory symptoms
NCT02294279Phase 4Completed
- Sponsor
- Research in Real-Life
- Start
- May 2014
- Primary completion
- Aug 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of beclomethasone in asthma, sponsored by Research in Real-Life. Primary endpoint: Asthma Control Questionnaire at 4 weeks. Started May 2014; status: completed.
02
Drugs
beclomethasone
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02294279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02294279.